Lara Slawik

A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia

John F. P. Bridges, Lara Slawik, A Schmeding et al. · Health Expectations · 2011 · 71 citations · Full text

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective

Jan Zeidler, Lara Slawik, Jochen Fleischmann et al. · Health Economics Review · 2012 · 41 citations · Full text

Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?

Michael Berek, Andreas Kordon, L. Hargarter et al. · Child and Adolescent Psychiatry and Mental Health · 2011 · 15 citations · Full text

Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study

Christian Wolff, Adam Alfred, Anton Lindermüller et al. · Current Medical Research and Opinion · 2011 · 11 citations

Transitioning to OROS^®methylphenidate from atomoxetine is effective in children and adolescents with ADHD

Käthe Niederkirchner, Lara Slawik, Detlef Wermelskirchen et al. · Expert Review of Neurotherapeutics · 2011 · 10 citations